The global histology and cytology market size is expected to reach USD 37.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 13.1% from 2021 to 2028. The factors contributing to market growth include increasing incidence of cancer, development of advanced tools for early disease diagnosis, implementation of immunohistochemistry, and innovation in microscopy.
In addition, organizations are collaborating for the standardization of cytopathology across the world, which is driving the market. For instance, in May 2020, International Agency for Research on Cancer (IARC) entered in collaboration with The International Academy of Cytology (IAC) for publishing a series of cytopathology reporting systems, for presenting an international approach that can be used for cytopathology of different body sites. The two organizations are engaged in the expansion and development of internationally recognized diagnostic reports for cancer and other precancerous disorders worldwide.
Moreover, companies are launching new and automated instruments for cytology which can be further attributed to the market growth. For instance, ELITechGroup Inc., in March 2020, launched Aerospray Cytology Slide Stainer Cytocentrifuge. It helps in the automation of the staining and preparation of specimens that are used in liquid-based cytology for facilitating the investigation of a collection of cell differentiation by using Papanicolaou staining techniques.
COVID-19 has become a catalyst for changing traditional pathology workflows with the integration of Artificial Intelligence (AI) and digitalization solutions. During the pandemic, these tools have helped and continue to assist in remote reviewing of pathological cases hence preventing delay in patient care. Companies have reported the increasing adoption of digital pathology solutions post COVID-19.
Request a free sample copy or view report summary: Histology And Cytology Market Report
The cytology segment accounted for the largest revenue share in 2020 and is expected to continue the trend in the forecast period owing to the integration of computational analytical tools for advancing cytology system
The histology is expected to witness gradual growth from 2021 to 2028 owing to moderate innovation in histological systems
The consumables and reagents segment dominated the market, attributed to the expanding portfolios of the entities operating in the consumable market space
The instruments and analysis software system segment is expected to witness a substantial CAGR from 2021 to 2028, attributed to the steep increase in the demand for automated histology instruments
The cervical cancer segment represented the majority of the market in 2020 owing to the increasing application of the Pap test in the early diagnosis of cervical cancer
Institutes are integrating computer algorithm for improving the accuracy and efficiency of cervical cancer screening
For instance, in June 2020, an NIH study integrated a computer algorithm with cytology (Pap test) for increasing the efficiency of cervical cancer screening. The new approach involves an AI platform for dual-stain evaluation
The other cancers segment is expected to witness a lucrative growth rate of 18.0% owing to increasing diagnosis of various cancers such as pancreatic cancer and bladder cancer with histopathology and cytopathology
The drug discovery and designing segment accounted for the highest revenue share in 2020 owing to the growing importance of cytopathology in disease understanding, further aimed at rapid drug development
North America accounted for the highest revenue share in 2020, owing to the prevalence of cancer, presence of key players, and developed healthcare infrastructure
Grand View Research has segmented the global histology and cytology market on the basis of type of examination, product, application, and region:
Histology & Cytology Type Of Examination Outlook (Revenue, USD Million, 2017 - 2028)
Cryostat & Microtomy
Cryostat & Microtomy
Histology & Cytology Product Outlook (Revenue, USD Million, 2017 - 2028)
Instruments and Analysis Software System
Consumable and Reagents
Histology & Cytology Application Outlook (Revenue, USD Million, 2017 - 2028)
Drug Discovery & Designing
Histology & Cytology Regional Outlook (Revenue, USD Million, 2017 - 2028)
Middle East & Africa
List of Key Players of Histology And Cytology Market
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Thermo Fisher Scientific, Inc.
Koninklijke Philips N.V.
This report has a service guarantee. We stand by our report quality.
Your transaction & personal information is safe and secure.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
Avail customized purchase options to meet your research needs:
"The quality of research they have done for us has been excellent..."